DC 6014Organs of Special Sense38 CFR § 4.79

Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)

The VA rates Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) under Diagnostic Code 6014 at a single 100% level. At 100%, veterans receive $3939/month or more in compensation.

Rating schedule — DC 6014 at a glance

Minimum rating
100%

Lowest schedular rating available

Maximum rating
100%

Full schedular disability

Rating tiers
1

100%

CFR section
§ 4.79

Part 4 rating schedule

Body system
Organs of Special Sense
Secondary conditions
0

None mapped

What are the VA rating criteria for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)?

RatingCriteria
100%

Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation

Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation

Common Questions About Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) VA Ratings

What is the VA rating range for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)?

The VA rates Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) under Diagnostic Code 6014 at 100%. The minimum 100% rating requires: Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation. The maximum 100% rating requires: Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation.

Which 38 CFR diagnostic code does the VA use for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)?

The VA rates Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) under Diagnostic Code (DC) 6014, governed by 38 CFR 38 CFR § 4.79. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.

Can Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) qualify for TDIU?

Yes — a 100% rating for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) alone meets the single-disability threshold for TDIU (38 CFR § 4.16). If the condition prevents substantially gainful employment, the veteran is compensated at the 100% rate without a schedular 100% rating.

What evidence supports a higher rating for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)?

The key evidence for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) is documentation of how the condition affects daily functioning. Treatment records showing worsening symptoms, functional limitations documented by your provider, and buddy statements describing observable impact on daily life all strengthen the claim. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.

What happens at the C&P exam for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)?

The C&P examiner uses a Organs of Special Sense DBQ and evaluates your condition against the DC 6014 rating criteria. The examiner documents symptom frequency, severity, and functional impact. Bring all treatment records and describe your worst days, not your best — the VA rates on the full clinical picture across time, not a snapshot of one good day.

Get a Personalized Rating Analysis

VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.

Discover Your Benefits